Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

P. Kenemans; N.J. Bundred; J.M. Foidart; E. Kubista; B. von Schoultz; P. Sismondi; R. Vassilopoulou-Sellin; C.H. Yip; J.C. Egberts; M. Mol-Arts; R. Mulder; S. van Os; M.W. Beckmann

doi:https://doi.org/10.1016/S1470-2045(08)70341-3

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

P. Kenemans, N.J. Bundred, J.M. Foidart, E. Kubista, B. von Schoultz, P. Sismondi, R. Vassilopoulou-Sellin, C.H. Yip, J.C. Egberts, M. Mol-Arts, R. Mulder, S. van Os, M.W. Beckmann

Obstetrics and gynaecology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

260 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	135-146
Journal	lancet oncology
Volume	10
Issue number	2
DOIs	https://doi.org/10.1016/S1470-2045(08)70341-3
Publication status	Published - 2009

Access to Document

https://doi.org/10.1016/S1470-2045(08)70341-3

Cite this

Kenemans, P., Bundred, N. J., Foidart, J. M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C. H., Egberts, J. C., Mol-Arts, M., Mulder, R., van Os, S., & Beckmann, M. W. (2009). Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. lancet oncology, 10(2), 135-146. https://doi.org/10.1016/S1470-2045(08)70341-3

@article{9781e91fe11647248e48b910f2be50df,

title = "Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial",

author = "P. Kenemans and N.J. Bundred and J.M. Foidart and E. Kubista and {von Schoultz}, B. and P. Sismondi and R. Vassilopoulou-Sellin and C.H. Yip and J.C. Egberts and M. Mol-Arts and R. Mulder and {van Os}, S. and M.W. Beckmann",

year = "2009",

doi = "https://doi.org/10.1016/S1470-2045(08)70341-3",

language = "Undefined/Unknown",

volume = "10",

pages = "135--146",

journal = "lancet oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

Kenemans, P, Bundred, NJ, Foidart, JM, Kubista, E, von Schoultz, B, Sismondi, P, Vassilopoulou-Sellin, R, Yip, CH, Egberts, JC, Mol-Arts, M, Mulder, R, van Os, S & Beckmann, MW 2009, 'Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial', lancet oncology, vol. 10, no. 2, pp. 135-146. https://doi.org/10.1016/S1470-2045(08)70341-3

TY - JOUR

T1 - Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

AU - Kenemans, P.

AU - Bundred, N.J.

AU - Foidart, J.M.

AU - Kubista, E.

AU - von Schoultz, B.

AU - Sismondi, P.

AU - Vassilopoulou-Sellin, R.

AU - Yip, C.H.

AU - Egberts, J.C.

AU - Mol-Arts, M.

AU - Mulder, R.

AU - van Os, S.

AU - Beckmann, M.W.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.1016/S1470-2045(08)70341-3

DO - https://doi.org/10.1016/S1470-2045(08)70341-3

M3 - Article

SN - 1470-2045

VL - 10

SP - 135

EP - 146

JO - lancet oncology

JF - lancet oncology

IS - 2

ER -